Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Thanks in part to a Norwegian research biobank, researchers have generated important new insight into ADHD and how the condition manifests itself. Among other things, they have found that there is some overlap between ADHD and bipolar disorders with regard to rapid mood swings.

2 Mar 2011

Sleep loss have negative impact on neurobehavioral functioning in children with ADHD

A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.

2 Mar 2011

New research finds link between genomic variants in neurological processes and autism

New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered.

2 Mar 2011

KemPharm commences KP201 Phase 1 trial for pain

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers with KP201, its novel abuse deterrent prodrug of hydrocodone for pain. KP201 is a new chemical entity and is the most advanced opioid-based lead candidate in KemPharm's emerging pipeline.

22 Feb 2011

Amphetamine linked to development of Parkinson’s disease

New research suggests that taking prescription amphetamines may raise the risk of developing Parkinson’s disease later. But, the researchers noted that the study did not prove a cause-and-effect relationship and further investigation is warranted. The research was released Feb. 19, and is scheduled to be presented in April at the American Academy of Neurology’s annual meeting in Honolulu.

21 Feb 2011

Amphetamines appear to increase risk of developing Parkinson's disease: New research

New research shows people who have used amphetamines such as benzedrine and dexedrine appear to be at an increased risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

20 Feb 2011

Children with chronic health conditions may face increased risk of physical abuse

Children with chronic health conditions are 88% more likely to suffer physical abuse than healthy children, according to research in the March issue of Acta Paediatrica. They are also 154% more likely to suffer a combination of physical abuse and exposure to intimate partner violence than their healthy school friends.

17 Feb 2011

Measurements of hand movement control may help determine severity of ADHD in children

Measurements of hand movement control may help determine the severity of attention deficit hyperactivity disorder in children, according to joint studies published in the February 15, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

15 Feb 2011

Studies reveal markers for measuring ability of children with ADHD to control impulsive movements

Two research studies published today in Neurology®, the medical journal of the American Academy of Neurology, found markers for measuring the ability of children with Attention Deficit Hyperactivity Disorder (ADHD) to control impulsive movements, which may reveal insights into the neurobiology of ADHD, inform prognosis and guide treatments.

15 Feb 2011

Harmful effects of energy drinks on children

A new study published in the journal Pediatrics on Monday examined the risks of consumption of high-caffeine energy drinks on children and young adults. The study notes that these drinks are linked to an array of serious events like heart palpitations, high blood pressure and even cardiac arrest and death. The risk rises if young adults consuming the drink suffer from chronic diseases or take other medications.

14 Feb 2011

Children with ADHD may have greater risk of developing substance problems in adolescence, adulthood

Children with attention-deficit hyperactivity disorder are two to three times more likely than children without the disorder to develop serious substance abuse problems in adolescence and adulthood, according to a study by UCLA psychologists and colleagues at the University of South Carolina.

14 Feb 2011

Rhabdomyolysis episode at University of Iowa signals a public health crisis

On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis—muscle breakdown—are so rare that it suggests an additional causal factor, such as a drug.

10 Feb 2011

ADHD kids often suffer from other mental ailments: Study

As many as two thirds of American children suffering from attention-deficit/hyperactivity disorder, ADHD, also suffer other mental health and developmental conditions, such as learning disabilities and anxiety says a new study.

8 Feb 2011

Study finds increased prescription drug abuse among teens

Illicit drugs like marijuana, cocaine and heroin have always been a parent's nightmare. But perfectly legal and easily accessible prescription medications are now the recreational drugs of choice for many teenagers, prompting physicians at Johns Hopkins Children's Center to urge pediatricians to screen specifically for their abuse during routine visits.

4 Feb 2011

Ritalin may help improve brain function in children with iron deficiency

Ritalin may help improve brain function in adolescent rats that were iron deficient during infancy, according to a team of Penn State neuroscientists. This may have implications for iron-deficient human infants as well.

3 Feb 2011

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

2 Feb 2011

UB's therapeutic program helps teens with ADHD to become better drivers

A University at Buffalo researcher's work with a state-of-the-art driving simulator is making better drivers among those considered to be the most risky motorists on the road: teens with ADHD.

25 Jan 2011

Pisgah to scale-up patent-pending form of hydrocodone

As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.

19 Jan 2011

Only half of adolescents affected with severely impairing mental disorders receive treatment

A recent study by Merikangas and colleagues published in the January 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) shows that only half of adolescents that are affected with severely impairing mental disorders ever receive treatment for their disorders.

19 Jan 2011

Study highlights lack of treatment for adolescents with severe mental disorders

A recent study by Merikangas and colleagues published in the January 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry shows that only half of adolescents that are affected with severely impairing mental disorders ever receive treatment for their disorders.

19 Jan 2011

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Sleep loss have negative impact on neurobehavioral functioning in children with ADHD

New research finds link between genomic variants in neurological processes and autism

KemPharm commences KP201 Phase 1 trial for pain

Amphetamine linked to development of Parkinson’s disease

Amphetamines appear to increase risk of developing Parkinson's disease: New research

Children with chronic health conditions may face increased risk of physical abuse

Measurements of hand movement control may help determine severity of ADHD in children

Studies reveal markers for measuring ability of children with ADHD to control impulsive movements

Harmful effects of energy drinks on children

Children with ADHD may have greater risk of developing substance problems in adolescence, adulthood

Rhabdomyolysis episode at University of Iowa signals a public health crisis

ADHD kids often suffer from other mental ailments: Study

Study finds increased prescription drug abuse among teens

Ritalin may help improve brain function in children with iron deficiency

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

UB's therapeutic program helps teens with ADHD to become better drivers

Pisgah to scale-up patent-pending form of hydrocodone

Only half of adolescents affected with severely impairing mental disorders receive treatment

Study highlights lack of treatment for adolescents with severe mental disorders

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in